Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2019NatureOpen Access

Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

EPElísabeth Pérez-RuizInstituto de Investigación Biomédica de MálagaLMLuna MinuteHospital Universitario La PazIOItziar OtanoSpanish National Cancer Research Centre

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pérez-Ruiz et al. (2019) studied this question.

synapsesocial.com/papers/6a0cd0fd9d761985b14a4fb2https://doi.org/10.1038/s41586-019-1162-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment2014 · 565 citations
  2. 2Mechanism of Activation-Induced Cell Death of T Cells and Regulation of FasL Expression2014 · 131 citations
  3. 3Nivolumab plus Ipilimumab in Advanced Melanoma2013 · 4,263 citations
  4. 4Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor1997 · 946 citations
  5. 5Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer2011 · 389 citations